Although these studies did not investigate the expression of different activating and inhibitory cell surface receptors, they all report expansion of cytotoxic immune cell subsets after surgery, including NK cells, NKT cells and CD8+ T cells [30–32], suggesting a more active immune system in patients after tumor resection, which is in line with our results. The gene discussed is CD8A; the disease is neoplasm.